Cancer hospital, Chinese Academy of Medical Sciences
Cancer hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China12 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, adenoma, breast adenocarcinoma, breast disorder, breast neoplasm, bronchial neoplasm, bronchogenic carcinoma, cervix disorder, endocrine system disorder, endometrium neoplasm, epithelial neoplasm, fallopian tube cancer, fallopian tube disorder, fallopian tube neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, lung disorder, lung neoplasm, malignant endocrine neoplasm, mesothelial neoplasm, mesothelioma, neoplasm, non-small cell lung carcinoma, ovarian cancer, ovarian disorder, primary peritoneal carcinoma, respiratory system disorder, respiratory tract neoplasm, skin disorder, triple-negative breast carcinoma, uterine cancer, uterine disorder | Recruiting | Phase 1 / Phase 2 | 2026-10-07 | NCT05579366 | |
| SMP-656 for HER2-Positive Advanced Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Not yet recruiting | Phase 2 | 2026-07-24 | NCT07726342 | |
| Evaluation of NWRD09 for HPV-16 Related Cervical HSIL | Morphological and Microscopic Findings, Pathological Conditions, Signs and Symptoms, Squamous Intraepithelial Lesions | Not yet recruiting | Phase 2 | 2026-07-17 | NCT07712692 | |
| A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX43 in Advanced/Metastatic Solid Tumors | Advanced/Metastatic Malignant Solid Tumors | Enrolling by invitation | Phase 1 | 2026-05-29 | NCT06115642 | |
| TL938 and Trastuzumab for Patients With HER2-positive Metastatic Colorectal Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Recruiting | Phase 2 | 2026-04-28 | NCT06589830 | |
| A Study of BL-M07D1 in Patients With a Variety of Solid Tumors Including Locally Advanced or Metastatic HER2-positive/Low-expressing Urinary and Gastrointestinal Tumors | Her2-positive/Low-expression Urinary and Digestive Tract Tumors | Recruiting | Phase 1 / Phase 2 | 2026-04-08 | NCT06031584 | |
| An Open-label, First-in-Human, Dose-Escalation and Dose-Expansion Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPR1020 in Patients With Advanced Solid Tumors | Advanced Solid Tumors; PARP Inhibitor | Recruiting | Phase 1 / Phase 2 | 2026-02-05 | NCT07359066 | |
| Sacituzumab Govitecan Plus Bevacizumab in Metastatic TNBC | Advanced Breast Cancer | Enrolling by invitation | Phase 2 | 2026-01-22 | NCT07359404 | |
| Study of GV20-0251 in Participants With Solid Tumor Malignancies | Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, bronchial neoplasm, bronchogenic carcinoma, carcinoma, endometrium neoplasm, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, hepatocellular carcinoma, liver disorder, lung disorder, lung neoplasm, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, non-small cell lung carcinoma, primitive neuroectodermal tumor, respiratory system disorder, respiratory tract neoplasm, skin disorder, skin neoplasm, small cell lung carcinoma, uterine disorder | Recruiting | Phase 1 / Phase 2 | 2025-12-03 | NCT07070518 | |
| A Study of GFH375 in Patients With Advanced Solid Tumors With KRAS G12D Mutations | Advanced Solid Tumors; KRAS G12D Mutations | Recruiting | Phase 1 / Phase 2 | 2025-11-20 | NCT06500676 | |
| A Study of BL-M07D1 in Patients With HER2-expressing Recurrent or Metastatic Gynecologic Malignancies | Gynecological Malignancies | Recruiting | Phase 1 / Phase 2 | 2025-09-26 | NCT06131450 | |
| Sirolimus for Injection (Albumin-bound) in Combination With Endocrine Therapy for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Who Have Failed Standard Therapy | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 2 | 2025-05-04 | NCT06957379 |